---
alwaysApply: false
description: Demo Test Cases - Ready to Execute
globs:
---

# ðŸŽ¬ DEMO TEST CASES

**Date:** January 28, 2025  
**Status:** âœ… **READY TO EXECUTE**  
**Backend:** http://localhost:8000  
**Frontend:** http://localhost:5173

---

## ðŸŽ¯ DEMO 1: RESISTANCE PREDICTION (Multiple Myeloma)

### Test Case 1.1: DIS3 Mutation (HIGH Risk)

**Endpoint:** `POST /api/resistance/predict`

**Request:**
```json
{
  "disease": "myeloma",
  "mutations": [
    {
      "gene": "DIS3",
      "hgvs_p": "p.Arg819Ter"
    }
  ],
  "current_drug_class": "proteasome_inhibitor",
  "treatment_line": 1
}
```

**Expected Response:**
- `risk_level`: "HIGH"
- `relative_risk`: 2.08
- `p_value`: 0.0145
- `validation_source`: "MMRF_CoMMpass_995"
- `alternatives`: Array with carfilzomib, daratumumab

**Frontend:** Navigate to `/myeloma` page, input DIS3 mutation

---

### Test Case 1.2: NF1 Mutation (Ovarian Cancer)

**Request:**
```json
{
  "disease": "ovarian",
  "mutations": [
    {
      "gene": "NF1",
      "hgvs_p": "p.Arg1276Ter"
    }
  ],
  "current_drug_class": "platinum",
  "treatment_line": 1
}
```

**Expected Response:**
- `risk_level`: "MEDIUM-HIGH" or "HIGH"
- `relative_risk`: ~2.10
- `p_value`: <0.05
- `alternatives`: Array with MAPK-targeting drugs

**Frontend:** Navigate to `/ovarian` page, input NF1 mutation

---

## ðŸŽ¯ DEMO 2: DRUG EFFICACY (S/P/E Framework)

### Test Case 2.1: MBD4+TP53 Patient (Should Rank PARP #1-3)

**Endpoint:** `POST /api/efficacy/predict`

**Request:**
```json
{
  "mutations": [
    {
      "gene": "MBD4",
      "hgvs_p": "p.Arg1239del",
      "chrom": "3",
      "pos": 129430000,
      "ref": "A",
      "alt": ""
    },
    {
      "gene": "TP53",
      "hgvs_p": "p.Arg273His",
      "chrom": "17",
      "pos": 7673800,
      "ref": "G",
      "alt": "A"
    }
  ],
  "disease": "ovarian",
  "model_id": "evo2_1b",
  "options": {
    "adaptive": true,
    "ensemble": false
  }
}
```

**Expected Response:**
- `drugs`: Array with PARP inhibitors (olaparib, niraparib, rucaparib) ranked #1-3
- `provenance`: Contains S/P/E breakdown
- `confidence_breakdown`: Shows sequence, pathway, evidence scores

**Frontend:** Navigate to `/clinical-genomics` or use `EfficacyPanel.jsx`

---

## ðŸŽ¯ DEMO 3: VUS RESOLUTION

### Test Case 3.1: RAD51C Variant (Should Resolve to "Likely damaging")

**Endpoint:** `POST /api/vus/identify`

**Request:**
```json
{
  "gene": "RAD51C",
  "chrom": "17",
  "pos": 58709872,
  "ref": "T",
  "alt": "C",
  "assembly": "GRCh38"
}
```

**Expected Response:**
- `triage.verdict`: "Likely damaging (ML)" or "Likely pathogenic"
- `provenance.resolution_path`: "evo2"
- `sequence.min_delta`: Negative value (damaging)
- `pathway_context.pathway_relevance`: "high" (DDR pathway)

**Frontend:** Navigate to `/mutation-explorer`, input RAD51C variant

---

### Test Case 3.2: Known Benign Variant

**Request:**
```json
{
  "gene": "BRCA1",
  "hgvs_c": "c.81C>T",
  "assembly": "GRCh38"
}
```

**Expected Response:**
- `triage.verdict`: "Benign" or "Likely benign"
- `provenance.resolution_path`: "prior" (ClinVar)
- `coverage.clinvar.status`: "Benign"

---

## ðŸŽ¯ DEMO 4: TRIAL MATCHING

### Test Case 4.1: DDR-High Patient (MBD4+TP53)

**Endpoint:** `POST /api/trials/agent/search`

**Request:**
```json
{
  "disease": "ovarian",
  "mutations": [
    {"gene": "MBD4", "hgvs_p": "p.Arg1239del"},
    {"gene": "TP53", "hgvs_p": "p.Arg273His"}
  ],
  "tumor_context": {
    "tmb": 8.5,
    "msi_status": "MSS"
  }
}
```

**Expected Response:**
- `matched_trials`: Array of trials
- Top trials should include PARP inhibitors, ATR inhibitors
- `total_found`: >0
- `excluded_count`: Number of filtered trials

**Frontend:** Navigate to `/ayesha-trials` or use `AutonomousTrialAgent.jsx`

---

## ðŸŽ¯ DEMO 5: METASTASIS ASSESSMENT

### Test Case 5.1: KRAS G12C Variant

**Endpoint:** `POST /api/metastasis/assess`

**Request:**
```json
{
  "gene": "KRAS",
  "hgvs_p": "p.Gly12Cys",
  "chrom": "12",
  "pos": 25398284,
  "ref": "G",
  "alt": "T"
}
```

**Expected Response:**
- `metastatic_potential`: Score
- `pathway_analysis`: MAPK pathway details
- `interception_targets`: Array of potential targets

**Frontend:** Navigate to `/metastasis-dashboard`

---

## ðŸŽ¯ DEMO 6: SYNTHETIC LETHALITY

### Test Case 6.1: KRAS G12C Synthetic Lethal Partners

**Endpoint:** `POST /api/guidance/synthetic_lethality`

**Request:**
```json
{
  "gene": "KRAS",
  "hgvs_p": "p.Gly12Cys",
  "disease": "lung"
}
```

**Expected Response:**
- `synthetic_lethal_partners`: Array of genes
- `confidence`: Scores for each partner
- `evidence`: Literature support

**Frontend:** Navigate to `/synthetic-lethality` or use `SyntheticLethalityDetective.jsx`

---

## ðŸš€ QUICK DEMO SCRIPT

### 1. Test Backend Health
```bash
curl http://localhost:8000/api/health
```

### 2. Test Resistance Prediction (DIS3)
```bash
curl -X POST http://localhost:8000/api/resistance/predict \
  -H "Content-Type: application/json" \
  -d '{
    "disease": "myeloma",
    "mutations": [{"gene": "DIS3", "hgvs_p": "p.Arg819Ter"}],
    "current_drug_class": "proteasome_inhibitor",
    "treatment_line": 1
  }'
```

### 3. Test Drug Efficacy (MBD4+TP53)
```bash
curl -X POST http://localhost:8000/api/efficacy/predict \
  -H "Content-Type: application/json" \
  -d '{
    "mutations": [
      {"gene": "MBD4", "hgvs_p": "p.Arg1239del", "chrom": "3", "pos": 129430000, "ref": "A", "alt": ""},
      {"gene": "TP53", "hgvs_p": "p.Arg273His", "chrom": "17", "pos": 7673800, "ref": "G", "alt": "A"}
    ],
    "disease": "ovarian",
    "model_id": "evo2_1b"
  }'
```

### 4. Test VUS Resolution (RAD51C)
```bash
curl -X POST http://localhost:8000/api/vus/identify \
  -H "Content-Type: application/json" \
  -d '{
    "gene": "RAD51C",
    "chrom": "17",
    "pos": 58709872,
    "ref": "T",
    "alt": "C",
    "assembly": "GRCh38"
  }'
```

### 5. Test Trial Matching
```bash
curl -X POST http://localhost:8000/api/trials/agent/search \
  -H "Content-Type: application/json" \
  -d '{
    "disease": "ovarian",
    "mutations": [
      {"gene": "MBD4", "hgvs_p": "p.Arg1239del"},
      {"gene": "TP53", "hgvs_p": "p.Arg273His"}
    ]
  }'
```

---

## ðŸ“Š FRONTEND DEMO PAGES

1. **Resistance Prediction:**
   - `/myeloma` - Multiple Myeloma resistance panel
   - `/ovarian` - Ovarian cancer resistance panel

2. **Drug Efficacy:**
   - `/clinical-genomics` - Clinical Genomics Command Center
   - `/hypothesis-validator` - Hypothesis Validator with S/P/E

3. **VUS Resolution:**
   - `/mutation-explorer` - Mutation Explorer with VUS resolution

4. **Trial Matching:**
   - `/ayesha-trials` - Ayesha Trial Explorer
   - `/agent-dashboard` - Autonomous Trial Agent

5. **Metastasis:**
   - `/metastasis-dashboard` - Metastasis Assessment Dashboard

6. **Synthetic Lethality:**
   - `/synthetic-lethality` - Synthetic Lethality Detective

---

## âœ… VERIFICATION CHECKLIST

- [ ] Backend running on http://localhost:8000
- [ ] Frontend running on http://localhost:5173
- [ ] Health endpoint responds
- [ ] Resistance prediction works (DIS3)
- [ ] Drug efficacy works (MBD4+TP53)
- [ ] VUS resolution works (RAD51C)
- [ ] Trial matching works (DDR-high patient)
- [ ] Frontend pages load correctly

---

*Document Author: Zo*  
*Last Updated: January 28, 2025*  
*Status: âœ… READY TO DEMO*

---

# ðŸŽ¬ DEMO TEST CASES

**Date:** January 28, 2025  
**Status:** âœ… **READY TO EXECUTE**  
**Backend:** http://localhost:8000  
**Frontend:** http://localhost:5173

---

## ðŸŽ¯ DEMO 1: RESISTANCE PREDICTION (Multiple Myeloma)

### Test Case 1.1: DIS3 Mutation (HIGH Risk)

**Endpoint:** `POST /api/resistance/predict`

**Request:**
```json
{
  "disease": "myeloma",
  "mutations": [
    {
      "gene": "DIS3",
      "hgvs_p": "p.Arg819Ter"
    }
  ],
  "current_drug_class": "proteasome_inhibitor",
  "treatment_line": 1
}
```

**Expected Response:**
- `risk_level`: "HIGH"
- `relative_risk`: 2.08
- `p_value`: 0.0145
- `validation_source`: "MMRF_CoMMpass_995"
- `alternatives`: Array with carfilzomib, daratumumab

**Frontend:** Navigate to `/myeloma` page, input DIS3 mutation

---

### Test Case 1.2: NF1 Mutation (Ovarian Cancer)

**Request:**
```json
{
  "disease": "ovarian",
  "mutations": [
    {
      "gene": "NF1",
      "hgvs_p": "p.Arg1276Ter"
    }
  ],
  "current_drug_class": "platinum",
  "treatment_line": 1
}
```

**Expected Response:**
- `risk_level`: "MEDIUM-HIGH" or "HIGH"
- `relative_risk`: ~2.10
- `p_value`: <0.05
- `alternatives`: Array with MAPK-targeting drugs

**Frontend:** Navigate to `/ovarian` page, input NF1 mutation

---

## ðŸŽ¯ DEMO 2: DRUG EFFICACY (S/P/E Framework)

### Test Case 2.1: MBD4+TP53 Patient (Should Rank PARP #1-3)

**Endpoint:** `POST /api/efficacy/predict`

**Request:**
```json
{
  "mutations": [
    {
      "gene": "MBD4",
      "hgvs_p": "p.Arg1239del",
      "chrom": "3",
      "pos": 129430000,
      "ref": "A",
      "alt": ""
    },
    {
      "gene": "TP53",
      "hgvs_p": "p.Arg273His",
      "chrom": "17",
      "pos": 7673800,
      "ref": "G",
      "alt": "A"
    }
  ],
  "disease": "ovarian",
  "model_id": "evo2_1b",
  "options": {
    "adaptive": true,
    "ensemble": false
  }
}
```

**Expected Response:**
- `drugs`: Array with PARP inhibitors (olaparib, niraparib, rucaparib) ranked #1-3
- `provenance`: Contains S/P/E breakdown
- `confidence_breakdown`: Shows sequence, pathway, evidence scores

**Frontend:** Navigate to `/clinical-genomics` or use `EfficacyPanel.jsx`

---

## ðŸŽ¯ DEMO 3: VUS RESOLUTION

### Test Case 3.1: RAD51C Variant (Should Resolve to "Likely damaging")

**Endpoint:** `POST /api/vus/identify`

**Request:**
```json
{
  "gene": "RAD51C",
  "chrom": "17",
  "pos": 58709872,
  "ref": "T",
  "alt": "C",
  "assembly": "GRCh38"
}
```

**Expected Response:**
- `triage.verdict`: "Likely damaging (ML)" or "Likely pathogenic"
- `provenance.resolution_path`: "evo2"
- `sequence.min_delta`: Negative value (damaging)
- `pathway_context.pathway_relevance`: "high" (DDR pathway)

**Frontend:** Navigate to `/mutation-explorer`, input RAD51C variant

---

### Test Case 3.2: Known Benign Variant

**Request:**
```json
{
  "gene": "BRCA1",
  "hgvs_c": "c.81C>T",
  "assembly": "GRCh38"
}
```

**Expected Response:**
- `triage.verdict`: "Benign" or "Likely benign"
- `provenance.resolution_path`: "prior" (ClinVar)
- `coverage.clinvar.status`: "Benign"

---

## ðŸŽ¯ DEMO 4: TRIAL MATCHING

### Test Case 4.1: DDR-High Patient (MBD4+TP53)

**Endpoint:** `POST /api/trials/agent/search`

**Request:**
```json
{
  "disease": "ovarian",
  "mutations": [
    {"gene": "MBD4", "hgvs_p": "p.Arg1239del"},
    {"gene": "TP53", "hgvs_p": "p.Arg273His"}
  ],
  "tumor_context": {
    "tmb": 8.5,
    "msi_status": "MSS"
  }
}
```

**Expected Response:**
- `matched_trials`: Array of trials
- Top trials should include PARP inhibitors, ATR inhibitors
- `total_found`: >0
- `excluded_count`: Number of filtered trials

**Frontend:** Navigate to `/ayesha-trials` or use `AutonomousTrialAgent.jsx`

---

## ðŸŽ¯ DEMO 5: METASTASIS ASSESSMENT

### Test Case 5.1: KRAS G12C Variant

**Endpoint:** `POST /api/metastasis/assess`

**Request:**
```json
{
  "gene": "KRAS",
  "hgvs_p": "p.Gly12Cys",
  "chrom": "12",
  "pos": 25398284,
  "ref": "G",
  "alt": "T"
}
```

**Expected Response:**
- `metastatic_potential`: Score
- `pathway_analysis`: MAPK pathway details
- `interception_targets`: Array of potential targets

**Frontend:** Navigate to `/metastasis-dashboard`

---

## ðŸŽ¯ DEMO 6: SYNTHETIC LETHALITY

### Test Case 6.1: KRAS G12C Synthetic Lethal Partners

**Endpoint:** `POST /api/guidance/synthetic_lethality`

**Request:**
```json
{
  "gene": "KRAS",
  "hgvs_p": "p.Gly12Cys",
  "disease": "lung"
}
```

**Expected Response:**
- `synthetic_lethal_partners`: Array of genes
- `confidence`: Scores for each partner
- `evidence`: Literature support

**Frontend:** Navigate to `/synthetic-lethality` or use `SyntheticLethalityDetective.jsx`

---

## ðŸš€ QUICK DEMO SCRIPT

### 1. Test Backend Health
```bash
curl http://localhost:8000/api/health
```

### 2. Test Resistance Prediction (DIS3)
```bash
curl -X POST http://localhost:8000/api/resistance/predict \
  -H "Content-Type: application/json" \
  -d '{
    "disease": "myeloma",
    "mutations": [{"gene": "DIS3", "hgvs_p": "p.Arg819Ter"}],
    "current_drug_class": "proteasome_inhibitor",
    "treatment_line": 1
  }'
```

### 3. Test Drug Efficacy (MBD4+TP53)
```bash
curl -X POST http://localhost:8000/api/efficacy/predict \
  -H "Content-Type: application/json" \
  -d '{
    "mutations": [
      {"gene": "MBD4", "hgvs_p": "p.Arg1239del", "chrom": "3", "pos": 129430000, "ref": "A", "alt": ""},
      {"gene": "TP53", "hgvs_p": "p.Arg273His", "chrom": "17", "pos": 7673800, "ref": "G", "alt": "A"}
    ],
    "disease": "ovarian",
    "model_id": "evo2_1b"
  }'
```

### 4. Test VUS Resolution (RAD51C)
```bash
curl -X POST http://localhost:8000/api/vus/identify \
  -H "Content-Type: application/json" \
  -d '{
    "gene": "RAD51C",
    "chrom": "17",
    "pos": 58709872,
    "ref": "T",
    "alt": "C",
    "assembly": "GRCh38"
  }'
```

### 5. Test Trial Matching
```bash
curl -X POST http://localhost:8000/api/trials/agent/search \
  -H "Content-Type: application/json" \
  -d '{
    "disease": "ovarian",
    "mutations": [
      {"gene": "MBD4", "hgvs_p": "p.Arg1239del"},
      {"gene": "TP53", "hgvs_p": "p.Arg273His"}
    ]
  }'
```

---

## ðŸ“Š FRONTEND DEMO PAGES

1. **Resistance Prediction:**
   - `/myeloma` - Multiple Myeloma resistance panel
   - `/ovarian` - Ovarian cancer resistance panel

2. **Drug Efficacy:**
   - `/clinical-genomics` - Clinical Genomics Command Center
   - `/hypothesis-validator` - Hypothesis Validator with S/P/E

3. **VUS Resolution:**
   - `/mutation-explorer` - Mutation Explorer with VUS resolution

4. **Trial Matching:**
   - `/ayesha-trials` - Ayesha Trial Explorer
   - `/agent-dashboard` - Autonomous Trial Agent

5. **Metastasis:**
   - `/metastasis-dashboard` - Metastasis Assessment Dashboard

6. **Synthetic Lethality:**
   - `/synthetic-lethality` - Synthetic Lethality Detective

---

## âœ… VERIFICATION CHECKLIST

- [ ] Backend running on http://localhost:8000
- [ ] Frontend running on http://localhost:5173
- [ ] Health endpoint responds
- [ ] Resistance prediction works (DIS3)
- [ ] Drug efficacy works (MBD4+TP53)
- [ ] VUS resolution works (RAD51C)
- [ ] Trial matching works (DDR-high patient)
- [ ] Frontend pages load correctly

---

*Document Author: Zo*  
*Last Updated: January 28, 2025*  
*Status: âœ… READY TO DEMO*
